FIELD: medicine, pharmacy. SUBSTANCE: invention relates to development of the novel pharmaceutical composition containing bacterial collagenase. Pharmaceutical composition has collagenase from Streptomycins lavendulae taken in the amount 3-10 U/100 g of product and also antiseptic myramistin, proxanol and polyethylene glycol. New bacterial collagen-base pharmaceutical composition shows nontoxic nonallergenic properties that can be used for healing and cleaning the wound, burn and other damages of skin. EFFECT: enhanced effectiveness of composition. 2 cl, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ENZYMATIC WOUND HEALING MEDICATION | 2011 |
|
RU2484811C2 |
| SUBSTANCE FOR DERMATOLOGICAL MEDICAL PRODUCTS ON BASIS OF COLLAGENASE OF MICROBIC PARENTAGE ULTRALYSINE | 2007 |
|
RU2340371C1 |
| METHOD OF COLLAGENASE PREPARING | 0 |
|
SU1822879A1 |
| OINTMENT FOR BURNING AND INFECTED WOUND HEALING | 1999 |
|
RU2174389C2 |
| METHOD FOR PRODUCING A COLLAGENOLYTIC ENZYME | 2020 |
|
RU2758788C1 |
| WOUND DRESSING | 2007 |
|
RU2349348C1 |
| METHOD OF OBTAINING A HETEROGENEOUS DRUG BASED ON COLLAGENASE AND CHITOSAN | 2017 |
|
RU2678435C2 |
| ENZYME PREPARATION FOR UNHAIRING AND SOFTENING LEATHER-FUR RAW | 1995 |
|
RU2127311C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
| AGENT "KOLLAGEL" FOR TREATMENT OF SUPPURATIVE-NECROTIC WOUNDS AND BURNS | 1997 |
|
RU2139044C1 |
